EP1776139A4 - Targeting damaged lung tissue - Google Patents

Targeting damaged lung tissue

Info

Publication number
EP1776139A4
EP1776139A4 EP05786087A EP05786087A EP1776139A4 EP 1776139 A4 EP1776139 A4 EP 1776139A4 EP 05786087 A EP05786087 A EP 05786087A EP 05786087 A EP05786087 A EP 05786087A EP 1776139 A4 EP1776139 A4 EP 1776139A4
Authority
EP
European Patent Office
Prior art keywords
lung tissue
damaged lung
targeting damaged
targeting
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05786087A
Other languages
German (de)
French (fr)
Other versions
EP1776139A2 (en
Inventor
Glen Gong
Ronald Dieck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PneumRx LLC
Original Assignee
PneumRx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/008,649 external-priority patent/US20050281739A1/en
Priority claimed from US11/008,094 external-priority patent/US20050281798A1/en
Priority claimed from US11/008,577 external-priority patent/US20050281799A1/en
Priority claimed from US11/008,093 external-priority patent/US7608579B2/en
Priority claimed from US11/008,092 external-priority patent/US20050281796A1/en
Priority claimed from US11/008,087 external-priority patent/US7678767B2/en
Priority claimed from US11/008,777 external-priority patent/US20050281740A1/en
Priority claimed from US11/008,782 external-priority patent/US7553810B2/en
Application filed by PneumRx LLC filed Critical PneumRx LLC
Publication of EP1776139A2 publication Critical patent/EP1776139A2/en
Publication of EP1776139A4 publication Critical patent/EP1776139A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP05786087A 2004-06-16 2005-06-13 Targeting damaged lung tissue Withdrawn EP1776139A4 (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US58044404P 2004-06-16 2004-06-16
US58693204P 2004-07-08 2004-07-08
US58695004P 2004-07-08 2004-07-08
US11/008,649 US20050281739A1 (en) 2004-06-16 2004-12-08 Imaging damaged lung tissue using compositions
US11/008,094 US20050281798A1 (en) 2004-06-16 2004-12-08 Targeting sites of damaged lung tissue using composition
US11/008,577 US20050281799A1 (en) 2004-06-16 2004-12-08 Targeting damaged lung tissue using compositions
US11/008,093 US7608579B2 (en) 2004-06-16 2004-12-08 Lung volume reduction using glue compositions
US11/008,092 US20050281796A1 (en) 2004-06-16 2004-12-08 Targeting damaged lung tissue
US11/008,580 US7468350B2 (en) 2004-06-16 2004-12-08 Glue composition for lung volume reduction
US11/008,087 US7678767B2 (en) 2004-06-16 2004-12-08 Glue compositions for lung volume reduction
US11/008,578 US20050281800A1 (en) 2004-06-16 2004-12-08 Targeting sites of damaged lung tissue
US11/008,777 US20050281740A1 (en) 2004-06-16 2004-12-08 Imaging damaged lung tissue
US11/008,782 US7553810B2 (en) 2004-06-16 2004-12-08 Lung volume reduction using glue composition
PCT/US2005/020993 WO2006009699A2 (en) 2004-06-16 2005-06-13 Targeting damaged lung tissue

Publications (2)

Publication Number Publication Date
EP1776139A2 EP1776139A2 (en) 2007-04-25
EP1776139A4 true EP1776139A4 (en) 2009-08-19

Family

ID=35785650

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05786087A Withdrawn EP1776139A4 (en) 2004-06-16 2005-06-13 Targeting damaged lung tissue

Country Status (3)

Country Link
EP (1) EP1776139A4 (en)
JP (1) JP2008503465A (en)
WO (1) WO2006009699A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055950A2 (en) * 2005-11-02 2007-05-18 Aeris Therapeutics, Inc. Polycation-polyanion complexes, compositions and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565842B1 (en) * 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
CA2410577A1 (en) * 2000-05-23 2001-12-13 The Trustees Of Columbia University In The City Of New York Method for treating respiratory disorders associated with pulmonary elastic fiber injury

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CANTIN ANDRE M ET AL: "Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha1 proteinase inhibitor.", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, vol. 27, no. 6, December 2002 (2002-12-01), pages 659 - 665, XP002534785, ISSN: 1044-1549 *
FERKOL T ET AL: "Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 167, no. 10, 15 May 2003 (2003-05-15), pages 1374 - 1379, XP009022239, ISSN: 1073-449X *

Also Published As

Publication number Publication date
WO2006009699A2 (en) 2006-01-26
EP1776139A2 (en) 2007-04-25
JP2008503465A (en) 2008-02-07
WO2006009699A3 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
HUE032742T2 (en) Inhaler
EP1721568A4 (en) Endoscope
EP1681013A4 (en) Endoscope
EP1764028A4 (en) Endoscope
EP1764027A4 (en) Endoscope
EP1718193A4 (en) Endoscope assembly
GB0520794D0 (en) Inhaler
GB0709512D0 (en) Disposable inhaler
GB0519151D0 (en) Inhaler
EP1859828A4 (en) Inhaler
GB0407990D0 (en) Inhaler
EP1772095A4 (en) Endoscope
EP1776139A4 (en) Targeting damaged lung tissue
GB2410192B (en) An inhaler
GB0405397D0 (en) An inhaler
GB0423511D0 (en) Inhaler
GB0619783D0 (en) Self-propelled skates
GB0510091D0 (en) Inhaler
IL177596A0 (en) Inhalation formulations
GB2415909B (en) Medical Aid
IL177148A0 (en) Endoscope assembly
GB2417424B (en) Artificial lung naturally driven
GB0418877D0 (en) Heart
GB2430622B (en) Inhaled combination therapy
AP2007003999A0 (en) Inhaler

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070112

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

R17D Deferred search report published (corrected)

Effective date: 20070322

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 9/66 20060101ALI20070403BHEP

Ipc: A61K 49/00 20060101ALI20070403BHEP

Ipc: A61K 38/00 20060101AFI20070403BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090716

17Q First examination report despatched

Effective date: 20091103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120403